Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M41,473Revenue $M5,770Net Margin (%)-15.0Z-Score1.0
Enterprise Value $M58,397EPS $-2.7Operating Margin %-7.1F-Score4
P/E(ttm))0Cash Flow Per Share $4.9Pre-tax Margin (%)-22.8Higher ROA y-yN
Price/Book8.210-y EBITDA Growth Rate %4.8Quick Ratio1.2Cash flow > EarningsY
Price/Sales6.25-y EBITDA Growth Rate %41.6Current Ratio1.5Lower Leverage y-yN
Price/Cash Flow11.8y-y EBITDA Growth Rate %34.9ROA % (ttm)-3.1Higher Current Ratio y-yY
Dividend Yield %0Insider Buy (3m)1ROE % (ttm)-16.9Less Shares Outstanding y-yN
Payout Ratio %0Shares Outstanding M335ROI % (ttm)-4.0Gross Margin Increase y-yN

Gurus Latest Trades with VRX

Number of guru portfolios checked: 56.
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
VRXLee Ainslie 2014-03-31 Add1.46%$112.62 - $148
($136.19)
$ 123.7-9%Add 48.23%2,421,778
VRXJohn Paulson 2014-03-31 Buy 0.65%$112.62 - $148
($136.19)
$ 123.7-9%New holding, 1000000 sh.1,000,000
VRXSteve Mandel 2014-03-31 Add0.61%$112.62 - $148
($136.19)
$ 123.7-9%Add 13.67%8,816,702
VRXDaniel Loeb 2014-03-31 Buy 0.48%$112.62 - $148
($136.19)
$ 123.7-9%New holding, 250000 sh.250,000
VRXGeorge Soros 2014-03-31 Buy 0.22%$112.62 - $148
($136.19)
$ 123.7-9%New holding, 165411 sh.165,411
VRXGlenn Greenberg 2014-03-31 Reduce-2.5%$112.62 - $148
($136.19)
$ 123.7-9%Reduce -8.52%5,592,558
VRXWallace Weitz 2014-03-31 Reduce-0.99%$112.62 - $148
($136.19)
$ 123.7-9%Reduce -13.61%1,597,540
VRXLou Simpson 2014-03-31 Reduce-0.25%$112.62 - $148
($136.19)
$ 123.7-9%Reduce -2.65%1,614,593
VRXMariko Gordon 2014-03-31 Reduce-0.1%$112.62 - $148
($136.19)
$ 123.7-9%Reduce -45.69%24,276
VRXLee Ainslie 2013-12-31 Buy 2.5%$103.04 - $117.42
($109.47)
$ 123.713%New holding, 1633838 sh.1,633,838
VRXJulian Robertson 2013-12-31 Sold Out -2.5%$103.04 - $117.42
($109.47)
$ 123.713%Sold Out0
VRXGlenn Greenberg 2013-12-31 Reduce-2.16%$103.04 - $117.42
($109.47)
$ 123.713%Reduce -7%6,113,227
VRXWallace Weitz 2013-12-31 Reduce-0.76%$103.04 - $117.42
($109.47)
$ 123.713%Reduce -9.48%1,849,200
VRXRuane Cunniff 2013-12-31 Reduce-0.21%$103.04 - $117.42
($109.47)
$ 123.713%Reduce -0.99%34,305,656
VRXJulian Robertson 2013-09-30 Reduce-1.57%$88.77 - $106.12
($97.46)
$ 123.727%Reduce -47.49%157,000
VRXLee Ainslie 2013-09-30 Sold Out -0.65%$88.77 - $106.12
($97.46)
$ 123.727%Sold Out0
VRXGlenn Greenberg 2013-09-30 Reduce-0.33%$88.77 - $106.12
($97.46)
$ 123.727%Reduce -1.26%6,573,589
VRXWallace Weitz 2013-09-30 Reduce-0.18%$88.77 - $106.12
($97.46)
$ 123.727%Reduce -2.5%2,042,835
VRXJean-Marie Eveillard 2013-09-30 Reduce-0.08%$88.77 - $106.12
($97.46)
$ 123.727%Reduce -23.45%902,742
VRXSteve Mandel 2013-06-30 Add1.32%$71.79 - $91.8
($78.8)
$ 123.757%Add 63.1%8,012,507
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

VRX is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
VRX George Soros 2014-03-31165,4110.050.22New Buy
VRX Daniel Loeb 2014-03-31250,0000.070.48New Buy
VRX John Paulson 2014-03-311,000,0000.30.65New Buy
VRX Lee Ainslie 2014-03-312,421,7780.724.5+48.23%
VRX Steve Mandel 2014-03-318,816,7022.635.1+13.67%
VRX Jeff Ubben 2014-03-3118,923,8775.6418.8
VRX Jean-Marie Eveillard 2014-03-31902,5420.270.32-0.02%
VRX Ruane Cunniff 2014-03-3134,217,36610.2124.1-0.26%
VRX Lou Simpson 2014-03-311,614,5930.489.3-2.65%
VRX Glenn Greenberg 2014-03-315,592,5581.6729.8-8.52%
VRX Wallace Weitz 2014-03-311,597,5400.486.7-13.61%
VRX Mariko Gordon 2014-03-3124,2760.010.13-45.69%
Premium Most recent portfolio changes are included for Premium Members only!


VRX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy. 2014-06-23Sell10,203$121.71.64view
Mirovsky PavelPresident of Valeant Europe 2014-06-02Sell10,000$131.25-5.75view
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy. 2014-05-13Sell10,000$130.08-4.9view
Provencio Norma AnnDirector 2014-04-01Sell5,000$132.18-6.42view
Kornwasser LaizerEVP, Company Group Chairman 2014-03-21Buy2,481$134.97-8.35view
Chai-Onn Robert RoswellEVP, Gen. Couns. & Corp. Secy. 2014-03-17Sell5,000$141.72-12.72view
Provencio Norma AnnDirector 2014-03-03Sell5,000$141.62-12.65view
Provencio Norma AnnDirector 2014-02-03Sell5,000$136.23-9.2view
Kornwasser LaizerEVP, Company Group Chairman 2014-01-24Buy2,536$132.15-6.39view
Provencio Norma AnnDirector 2014-01-13Sell5,000$133-6.99view

Press Releases about VRX :

    Quarterly/Annual Reports about VRX:

    News about VRX:

    Articles On GuruFocus.com
    Diamond Hill Capital Comments on Valeant Pharmaceuticals International Inc Jul 25 2014 
    Ackman Explains Valeant Bid, Makes Up with Carl Icahn Jun 09 2014 
    The Top Guru-Held Canadian Stocks of the First Quarter May 28 2014 
    Jim Chanos on Green Mountain Short, China Short, Valeant and Short Selling May 15 2014 
    Bill Ackman Interview: Forgiving Icahn, Valeant Merger, Fannie Mae and Freddie Mac May 05 2014 
    Mario Gabelli on Bill Ackman, Valeant, AT&T, DirecTV and Pfizer May 02 2014 
    Bill Ackman Sits Down With Bloomberg - Allergan Is Not Being Raided In Valeant Deal Apr 25 2014 
    Bill Ackman and Valeant Pharmaceuticals Team Up to Take Over Pharmaceutical Company Allergen Apr 23 2014 
    Carl Icahn on Apple, Ackman and Valeant, and Seeding Activist Funds Apr 23 2014 
    Bill Ackman Discusses Valeant on CNBC Apr 23 2014 


    More From Other Websites
    Business Highlights Jul 29 2014
    Merck Pops On Good Profits, Tax Deal? Jul 29 2014
    Will Express Scripts Miss Earnings Estimates this Season? Jul 28 2014
    [video] Allergan's Largest Shareholder Sells Most of Holdings Jul 28 2014
    [video] Inversion shame gone: NYT reporter Jul 28 2014
    3 Great Stocks to Buy If You Have $60,000 to Invest Jul 25 2014
    Obama calls on Congress to end inversion deals, NY Times reports Jul 25 2014
    UCB's Brivaracetam Positive in Phase III Epilepsy Study Jul 24 2014
    Botox Maker’s Bosses Put Money Where Their Mouths Are Jul 24 2014
    Wall Street Junk Euphoria Backs Ackman’s Allergan Dreams Jul 24 2014
    Valeant Pharmaceuticals Files An Official Complaint With The Autorite Des Marches Financiers About... Jul 24 2014
    Valeant files official complaint about Allergan with Canadian regulator Jul 24 2014
    Valeant Pharmaceuticals Files An Official Complaint With The Autorite Des Marches Financiers About... Jul 24 2014
    Valeant Pharmaceuticals Files An Official Complaint With The Autorite Des Marches Financiers About... Jul 24 2014
    Correction: Blog points out Valeant's diverse portfolio is key to its success Jul 23 2014
    Correcting an earlier blog post …. Jul 23 2014
    Ominous Signs For Valeant In The Allergan Q2 Earnings Call Jul 23 2014
    Danger Zone: Stocks With Most Misleading Non-GAAP Earnings Jul 23 2014
    [$$] Allergan Leaves Investors Smiling Jul 23 2014
    BTIG: Valeant Must Sweeten Allergan Bid To More Than $200/Share Jul 22 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK
    Email Hide